■ Bone health after diagnosis of breast cancer
S M Ruzyck, N A Nixon
CMAJ 2019, vol 191 (49): E1452
1 – Treatment of breast cancer may increase fracture risk
2 – Patients with breast cancer should be assessed for fracture risk using a validated tool
3 – Bone is the most common site of metástases for patients with breast cancer
4 – Bisphosphonates can reduce morbidity from boné metástases
5 – Bisphosphonates improve survival and prevent boné metastasis in postmenopausal women with early-stage breast câncer
https://www.cmaj.ca/content/190/49/E1452
■ Marijuana and fertility
S Ilnistsky, S Van Uum
CMAJ 2019, vol 191 (23): E638
1 – Tetrahydrocannabinol acts on the endocannabinoid system, wihich is ubiquitous in reproductive tissues
2 – Marijuana use can decrease serm count
3 – Marijuana use may delay or inhibit ovulation
4 – For most couples, smoking marijuana does not affect their ability to conceive, but for couples with subfertiligy or infertility, it could be a contributing fator
5 – More and better-quality research on the fertiligy implications of recreational marijuana use is needed
https://www.cmaj.ca/content/191/23/E638
■ Transgender-inclusive care
J S H Lam and A Abramovich
CMAJ 2019, vol 191 (18) E505
1 – Population studies estimate that 0,5% of adults (about 25 million people worldwide) identify as transgender
2 – Medical guidelines on providing care for transgender individuals have been published
3 – Trangender men with a cérvix are less likely than cisgender women to have up-to-date Papanicolau screening
4 – Fertility preservation should be discussed with transgender individuals before starting therapy
5 – Transgender individuals should be asked about suicidality and their mental health
https://www.cmaj.ca/content/191/3/E79
■ Opioid use disorder in pregnancy
A Ambasta, M Malebranche
CMAJ 2019, vol 191 (38): E1057
1 – In parallel with the opioid epidemic in the general population, opioid use and associated opioid use disorders in pregnancy are arising
2 – Guidelines support universal screening for drug use, including opioids by prenatal care
3 – Opioid-agonist therapy is the standart of care of opioid use disorders in pregnancy
4 – Neonatal opioid withdrawal syndrome is best managed by keepiing mothers and infants together after delivery
5 – Ongoing support in the postpartum period is essential
https://www.cmaj.ca/content/191/38/E1057
■ Gíinecologia & Obstetricia: Five Things to Know About I Online (Gynecology & Obstetrics: Five Things to Know About I)
■ Dr Paulo Fernando Leite
Cardiologia/Prevenção Cardiovascular
Estratificação de Risco Cardiovascular
Consultório: Rua Padre Rolim 815/sala 601
Tel: 33245518
CRMMG: 7026
Email: pfleite1873@gmail.com
Data: Fev 2020